📣 VC round data is live. Check it out!

Sensus Healthcare Valuation Multiples

Discover revenue and EBITDA valuation multiples for Sensus Healthcare and similar public comparables like Sequana Medical, Svas Biosana, SMAIO, K Pharma and more.

Sensus Healthcare Overview

About Sensus Healthcare

Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.


Founded

2010

HQ

United States

Employees

54

Financials (LTM)

Revenue: $26M
EBITDA: ($10M)

EV

$37M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Sensus Healthcare Financials

Sensus Healthcare reported last 12-month revenue of $26M and negative EBITDA of ($10M).

In the same LTM period, Sensus Healthcare generated $11M in gross profit, ($10M) in EBITDA losses, and had net loss of ($7M).

Revenue (LTM)


Sensus Healthcare P&L

In the most recent fiscal year, Sensus Healthcare reported revenue of $27M and EBITDA of ($10M).

Sensus Healthcare is unprofitable as of last fiscal year, with gross margin of 43%, EBITDA margin of (35%), and net margin of (28%).

See analyst estimates for Sensus Healthcare
LTMLast FY202320242025202620272028
Revenue$26M$27M$24M$42M$27M
Gross Profit$11M$12M$14M$24M$12M
Gross Margin42%43%58%58%43%
EBITDA($10M)($10M)$79K$9M($10M)
EBITDA Margin(39%)(35%)0%20%(35%)
EBIT Margin(38%)(37%)(2%)19%(38%)
Net Profit($7M)($8M)$485K$7M($8M)
Net Margin(28%)(28%)2%16%(28%)

Financial data powered by Morningstar, Inc.

Sensus Healthcare Stock Performance

Sensus Healthcare has current market cap of $55M, and enterprise value of $37M.

Market Cap Evolution


Sensus Healthcare's stock price is $3.36.

Sensus Healthcare share price decreased by 15.9% in the last 30 days, and by 29.4% in the last year.

Sensus Healthcare has an EPS (earnings per share) of $-0.47.

See more trading valuation data for Sensus Healthcare
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$37M$55M-3.2%-15.9%-18.2%-29.4%$-0.47

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Sensus Healthcare Valuation Multiples

Sensus Healthcare trades at 1.4x EV/Revenue multiple, and (3.7x) EV/EBITDA.

See NTM and 2027E valuation multiples for Sensus Healthcare

EV / Revenue (LTM)


Sensus Healthcare Financial Valuation Multiples

As of May 20, 2026, Sensus Healthcare has market cap of $55M and EV of $37M.

Sensus Healthcare has a P/E ratio of (7.7x).

LTMLast FY202320242025202620272028
EV/Revenue1.4x1.4x1.5x0.9x1.4x
EV/EBITDA(3.7x)(3.9x)n/m4.4x(3.9x)
EV/EBIT(3.8x)(3.6x)(97.9x)4.6x(3.6x)
EV/Gross Profit3.4x3.2x2.7x1.5x3.2x
P/E(7.7x)(7.2x)114.0x8.3x(7.2x)
EV/FCF112.6x(15.8x)(33.8x)112.6x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Sensus Healthcare Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Sensus Healthcare Margins & Growth Rates

Sensus Healthcare decreased revenue by 16% but EBITDA grew by 9% in the last fiscal year.

In the most recent fiscal year, Sensus Healthcare reported gross margin of 43%, EBITDA margin of (35%), and net margin of (28%).

See estimated margins and future growth rates for Sensus Healthcare

Sensus Healthcare Margins

Last FY202420252026202720282029
Gross Margin43%58%43%40%
EBITDA Margin(35%)20%(35%)(46%)
EBIT Margin(37%)19%(38%)(39%)
Net Margin(28%)16%(28%)(28%)
FCF Margin1%(3%)1%

Sensus Healthcare Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth(16%)71%(34%)(16%)
Gross Profit Growth(22%)74%(51%)(22%)
EBITDA Growth9%10687%(214%)9%
EBIT Growth(12%)(2218%)(227%)(12%)
Net Profit Growth(17%)1271%(216%)(17%)
FCF Growth(53%)(130%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Sensus Healthcare Operational KPIs

Sensus Healthcare's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.4M for the same period.

Sensus Healthcare's Rule of 40 is (61%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Sensus Healthcare's Rule of X is (85%) (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Sensus Healthcare
LTMLast FY202320242025202620272028
Rule of 40(34%)(61%)
Bessemer Rule of X(26%)(85%)
Revenue per Employee$0.5M
Opex per Employee$0.4M
S&M Expenses to Revenue26%24%23%12%24%
G&A Expenses to Revenue29%29%21%17%29%
R&D Expenses to Revenue26%28%15%10%28%
Opex to Revenue81%59%39%81%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Sensus Healthcare Competitors

Sensus Healthcare competitors include Sequana Medical, Svas Biosana, SMAIO, K Pharma, Modulight, Pulmonx, Envoy Medical, SciBase Holding, Anatolia Geneworks and Pentixapharm Holding.

Most Sensus Healthcare public comparables operate across Medical Devices, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Sequana Medical775.8x31.3x(2.0x)(4.0x)
Svas Biosana0.9x0.7x6.0x5.6x
SMAIO5.1x4.6x(52.9x)(53.9x)
K Pharma(7.4x)
Modulight5.5x5.3x(993.0x)87.9x
Pulmonx0.6x0.6x(1.5x)(1.6x)
Envoy Medical134.9x144.4x(1.5x)
SciBase Holding10.8x8.7x(5.3x)(5.7x)

This data is available for Pro users. Sign up to see all Sensus Healthcare competitors and their valuation data.

Start Free Trial

Sensus Healthcare Funding History

Before going public, Sensus Healthcare raised $1M in total equity funding, across 1 round.


Sensus Healthcare Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
Jan-13Seed$1M

Sensus Healthcare M&A Activity

Sensus Healthcare has acquired 1 company to date.

Last acquisition by Sensus Healthcare was on August 4th 2020. Sensus Healthcare acquired Aesthetic Mobile Laser for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Sensus Healthcare

Aesthetic Mobile Laser
Description
Aesthetic Mobile Laser is a mobile service provider delivering in-office laser platforms like Alma Harmony and Lutronic lasers to physicians in the Southeastern US. It supplies PicoSure for pigmentation and eMatrix for wrinkles, with technicians handling setup and training for OB-GYNs and primary care clinics expanding into aesthetics.
HQ CountryUnited States
HQ City
Fort Lauderdale, FL
Deal Date4 Aug 2020
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Sensus Healthcare acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Sensus Healthcare

When was Sensus Healthcare founded?Sensus Healthcare was founded in 2010.
Where is Sensus Healthcare headquartered?Sensus Healthcare is headquartered in United States.
How many employees does Sensus Healthcare have?As of today, Sensus Healthcare has over 54 employees.
Who is the CEO of Sensus Healthcare?Sensus Healthcare's CEO is Joseph Sardano.
Is Sensus Healthcare publicly listed?Yes, Sensus Healthcare is a public company listed on Nasdaq.
What is the stock symbol of Sensus Healthcare?Sensus Healthcare trades under SRTS ticker.
When did Sensus Healthcare go public?Sensus Healthcare went public in 2016.
Who are competitors of Sensus Healthcare?Sensus Healthcare main competitors include Sequana Medical, Svas Biosana, SMAIO, K Pharma, Modulight, Pulmonx, Envoy Medical, SciBase Holding, Anatolia Geneworks, Pentixapharm Holding.
What is the current market cap of Sensus Healthcare?Sensus Healthcare's current market cap is $55M.
What is the current revenue of Sensus Healthcare?Sensus Healthcare's last 12 months revenue is $26M.
What is the current revenue growth of Sensus Healthcare?Sensus Healthcare revenue growth (NTM/LTM) is 5%.
What is the current EV/Revenue multiple of Sensus Healthcare?Current revenue multiple of Sensus Healthcare is 1.4x.
Is Sensus Healthcare profitable?No, Sensus Healthcare is not profitable.
What is the current EBITDA of Sensus Healthcare?Sensus Healthcare has negative EBITDA and is not profitable.
What is Sensus Healthcare's EBITDA margin?Sensus Healthcare's last 12 months EBITDA margin is (39%).
What is the current EV/EBITDA multiple of Sensus Healthcare?Current EBITDA multiple of Sensus Healthcare is (3.7x).
How many companies Sensus Healthcare has acquired to date?As of May 2026, Sensus Healthcare has acquired 1 company.
What was the largest acquisition by Sensus Healthcare?None of the M&A deals Sensus Healthcare has completed have disclosed valuations.
What companies Sensus Healthcare acquired?Sensus Healthcare acquired Aesthetic Mobile Laser.
In how many companies Sensus Healthcare has invested to date?Sensus Healthcare hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Sensus Healthcare

Lists including Sensus Healthcare

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial